October 21, 2019

Stanford University, Berg Hall, Li Ka Shing Center (LKSC)

TOPS Annual Symposium: Translating Discoveries to Cures

This symposium brings together speakers from academia, industry and the FDA to discuss their perspectives on anticancer drug discovery and development.


Speakers

David Entwistle
CEO
Stanford Health Care

 

 

William Douglas Figg, PharmD
Deputy Chief, Genitourinary Malignancies Branch
Head, Molecular Pharmacology Section
Center for Cancer Research
National Cancer Institute

Shivaani Kummar, MD, FACP
Professor of Medicine (Oncology)
Stanford University School of Medicine

 

 

Sanjay Malhotra, PhD, FRSC
Associate Professor (Research), Radiation Oncology- Radiation and Cancer Biology and Radiology- Nuclear Medicine
Stanford University School of Medicine

Abhijit “Ron” Mazumder, PhD, MBA
Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics
Genentech

Lloyd Minor, MD
Dean
Stanford School of Medicine

 

Saranne Rothberg (Weill)
CEO
The ComedyCures Foundation

 

 

Ravi Salgia, MD, PhD
Arthur & Rosalie Kaplan Chair in Medical Oncology
Associate Director for Clinical Sciences Research
City of Hope Comprehensive Cancer Center

Nader Sanai, MD, FAANS, FACS
Francis and Dionne Najafi Professor of Neurosurgical Oncology
Director, Division of Neurosurgical Oncology
Director, Ivy Brain Tumor Center
Barrow Neurological Institute

George Sledge JR, MD, FASCO
Professor of Medcine (Oncology)
Stanford University School of Medicine

Anand Subramony, PhD, MS
Vice President of External innovation and Novel Technologies
AstraZeneca

Paul Yock, MD
Founder, Director, Stanford Biodesign
Professor of Medicine and Engineering
Stanford University

Laleh Amiri-Kordestani, MD
Associate Director, Division of Oncology Products 1
Center for Drug Evaluation and Research
FDA

Alex Aravanis, MD, PhD 
Chief Scientific Officer and Head of R&D
GRAIL

Matt Onsum, PhD
Director and Head of Bioinformatics
Seattle Genetics

Edward Chu, MD
Chief of Hematology/Oncology and Deputy Director
University of Pittsburgh Cancer Institute

Monica Motwani, PhD
Research Fellow, Translational Oncology
AbbVie

Chris H. Takimoto, MD, PhD, FACP
Chief Medical Officer
Forty Seven, Inc.

Agenda

Organizers

Shivaani Kummar, MD, FACP

Professor of Medicine (Oncology)
Stanford University School of Medicine

Sanjay Malhotra, PhD, FRSC

Associate Professor (Research), Radiation Oncology- Radiation and Cancer Biology and Radiology- Nuclear Medicine
Stanford University School of Medicine

George Sledge Jr, MD, FASCO

Professor of Medicine (Oncology)
Stanford University School of Medicine

Supported by